touchMDT - Coordinated care and evolving therapies: Implications for future pathways

Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss how evolving therapies are reshaping HS management and multidisciplinary care, with patient perspectives highlighting the impact of coordinated care and effective disease control.

The multidisciplinary team

• Dr. Melinda Gooderham - SKiN Centre for Dermatology, Peterborough, Ontario, Canada
• Prof. Dr. Falk Bechara - Ruhr University Bochum, Germany
• Dr. Daniel Stein - George Washington University, Washington, DC, USA

This touchPODCAST is for HCPs only.

This activity is supported by an independent medical education grant from UCB.

Jointly provided by Partners for Advancing Clinical Education and touchIME.

touchIME is an EBAC® accredited provider. 

For further information visit our website: 

touchDERMATOLOGY.com and touchIMMUNOLOGY.com